Effect of a Dietary Supplement on Quality of Life
SleepLift
A Cross-over Pilot Trial to Determine the Effect of an LSU Patented Dietary Herbal Supplement on Quality of Life
1 other identifier
interventional
10
1 country
1
Brief Summary
The purpose of this research study is to evaluate the effect of a combination of 3 food components to improve the quality of life in people who have trouble sleeping. Ten subjects with insomnia will drink 2 ounces of the supplement or a placebo for 1 week and after a 2 weeks washout period, will take the treatment they did not take the first week. Questionnaires to evaluate quality of life, and a sleep study will be done before and after each treatment week.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable quality-of-life
Started Feb 2022
Shorter than P25 for not_applicable quality-of-life
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 25, 2022
CompletedFirst Submitted
Initial submission to the registry
March 27, 2022
CompletedFirst Posted
Study publicly available on registry
April 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 7, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 7, 2022
CompletedResults Posted
Study results publicly available
September 19, 2024
CompletedDecember 16, 2024
November 1, 2024
6 months
March 27, 2022
September 18, 2023
November 26, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Chubon Lifestyle Score
Total score ranges from 20 to 140 with higher scores being better quality of life
1 week
Secondary Outcomes (5)
Pittsburgh Sleep Quality Index Score
1 week
Epworth Sleepiness Scale
1 week
Multidimensional Fatigue Index -General Fatigue
1-week
Multidimensional Fatigue Index - Physical Fatigue
1 week
Multidimensional Fatigue Index - Mental Fatigue
1 week
Other Outcomes (3)
Sleep Latency
1-week
Wake After Sleep Onset
1-week
Sleep Efficiency
1-week
Study Arms (2)
Dietary supplement
EXPERIMENTALGreen tea extract 5 grams, Chicory extract 1gram and collagen peptides 5 grams in 60ml with sugar, erythritol and 2% potassium sorbate and 1% flavor
Placebo
PLACEBO COMPARATOR60ml of water, sugar, erythritol, 2% potassium sorbate, and 1% flavor
Interventions
1 week of each intervention at bedtime with a 2-week washout period in between interventions
Eligibility Criteria
You may qualify if:
- Healthy men or women \>50 years of age
- Usual bedtime between 9pm and midnight
- Insomnia for \>6months by ICSD-2 criteria
- Insomnia Severity Index score \>10 and Sleep-onset latency or Waking after sleep onset \>30 minutes
You may not qualify if:
- Have diabetes mellitus
- Taking chronic medication not on a stable dose for \>1month
- Taking sedating or hypnotic medications
- Have a sleep disorder other than insomnia (like sleep apnea) Adults unable to consent Prisoners Pregnant women Individuals not yet adults
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pennington Biomedical Research Center
Baton Rouge, Louisiana, 70808-4124, United States
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Prachi Singh
- Organization
- Pennington Biomedical Research Institute
Study Officials
- STUDY CHAIR
Paula R Brantley, PhD
Pennington Biomedical Research Center Institutional Review Board
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Masking Details
- Liquid that looks and tastes the same, but only one has the three food components. The order in which the subjects get the 3-component supplement and the placebo is randomly assigned and balanced.
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Chief Medical Officer
Study Record Dates
First Submitted
March 27, 2022
First Posted
April 12, 2022
Study Start
February 25, 2022
Primary Completion
September 7, 2022
Study Completion
September 7, 2022
Last Updated
December 16, 2024
Results First Posted
September 19, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR
- Time Frame
- Study is expected to be done and report generated by June 2022
- Access Criteria
- Data can be accessed, if the use is approved by the PI
De-identified data will be made available on approval of the PI